RY

RYTHM, Inc.

RYMConsumer DefensiveNASDAQ

Tobacco

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$17.3M
+95916.7% YoY
Net Income
-$33.3M
+20.3% YoY
EBITDA
-$25.4M
-17.8% YoY
Free Cash Flow
$359,625

Scan Results

Daily timeframe
1 recent day hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 27.7, below 30, stock may be oversold
Oct 19CONFIRMED▲ RSI OversoldRSI 29.0, below 30, stock may be oversold
About RYTHM, Inc.

RYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. Valued at $33.6M, RYM is a micro-cap name in its sector. The company offers consumers hemp-derived tetrahydrocannabinol beverages, as well as other hemp-derived products through retailers, online, and direct-to-retail partnerships.

Where RYM stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, RYM finished 30.05% below its 150-day moving average ($23.53) and 25.86% below its 200-day moving average ($22.20). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is RYM overbought or oversold?

At the October 20, 2026 close, RYM's RSI(14) was 27.7, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$33.6M
EPS$-9.54
Beta9.45
52W Change-60.3%
Dividend Yield0.00%
ROE-10.5%
Analysis

The company holds $41.9M in cash, though total debt stands at $80.6M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $360K supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -10.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $58.3M (2022) to $17.3M (2025), a 70% decline worth watching.

RYTHM, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for RYTHM, Inc. and its sector.

Links
More Consumer Defensive stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms